Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

stock market

Nanox sees stock slide after revealing ongoing SEC investigation into its business practices

The Israeli imaging firm has spent $600,000 on legal fees related to the inquiry and other ongoing lawsuits, leaders said. 

Thumbnail

ACR committee proposes new term for symptoms associated with gadolinium exposure

The move can help providers avoid prematurely attributing symptoms to a specific disease, the college said.

M&A mergers and acquisitions business deal

GE’s plan to split in 3 sets stage for ‘feeding frenzy’ among private equity buyers

General Electric first announced the move Nov. 9, with the struggling industrial giant separating into firms focused on healthcare, aviation and energy

Thumbnail

Kaufman Hall acquires Healthcare Real Estate Capital

Kaufman, Hall & Associates has acquired Healthcare Real Estate Capital, a national advisory firm focused on the healthcare and higher education real estate capital markets sectors.

 

After months-long delay, imaging center operator Akumin reports Q2 earnings results

The publicly traded radiology firm logged 1.659M RVUs during the three months ending June 30, up 52% from last year.

hand x-ray radiograph

Hand trauma patients requiring radiology services face much higher odds of receiving surprise bill

Radiologists had the highest association among docs, presenting a 132% greater risk of an unanticipated IOU, experts wrote in the Journal of Hand Surgery. 

Thumbnail

130-year-old Johnson & Johnson will split into two public companies

J&J's consumer business—responsible for Tylenol, Band-Aid and more household names—will separate from its pharmaceutical and medical device division.

Biden expected to choose cardiologist who served under Obama as next FDA commissioner

Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine.